Thyroid Disorders

Thyroid cancer is a metastatic tumor of the thyroid gland. It is comparatively uncommon compared to other cancers. Within USA, it is calculated that in 2016 close to 64,000 new patients will be diagnosed with thyroid cancer, compared to more than 240,000 patients with breast cancer and 135,000 patients with colorectal cancer. However, fewer than 2,000 patients die of thyroid cancer annually. In 2013 over 630,000 patients were living with thyroid cancer within USA. Recent epidemiological data from WHO suggests that there are more than 750 million cases globally with a thyroid disorder. Increasing focus by government organizations and private agencies like WHO and pharmaceutical companies, to create awareness of thyroid deficiency is fuelling the market growth. Levothyroxine and Cytomel are the most selling drugs in the thyroid deficiency treatment market. Follow Endocrinology Conferences and Diabetes Conferences for more updates.

    Related Conference of Thyroid Disorders

    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    Paris, France
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland
    February 27-28, 2019

    Asia Pacific Diabetes and Endocrinology Congress

    Tokyo, Japan

    April 17-18, 2019

    21st Asia Pacific Diabetes Conference

    Osaka,Japan
    April 29-30, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey
    June 10-11, 2019

    28th European Diabetes Congress

    | Edinburgh, Scotland
    July 24-25, 2019

    29th World Diabetes & Heart Congress

    Melbourne, Australia
    July 29-30, 2019

    12th International Conference on Diabetes & Metabolism

    Chicago | Illinois| USA
    Oct 03-04, 2019

    Euro Diabetes Congress & Expo

    | Paris, France

    Thyroid Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in